|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.700 SEK | -1.36% |
|
+3.82% | -35.56% |
| 07/07 | Vivesto chairman Peter Zonabend increases his shareholding | FW |
| 01/07 | Vivesto Completes Enrollment in Cat Study of Paccal Vet | FW |
| Market Cap | 96.32M 10.16M 8.79M 8.21M 7.53M 14.17M 967M 14.39M 37.81M 485M 38.17M 37.33M 1.6B | P/E 2026 * |
-2.84x | P/E 2027 * | -2.08x |
|---|---|---|---|---|---|
| Enterprise Value | 88.32M 9.32M 8.06M 7.53M 6.91M 12.99M 887M 13.2M 34.67M 445M 35M 34.23M 1.47B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
52.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vivesto AB
| 1 day | -1.36% | ||
| 1 week | +3.82% | ||
| Current month | +3.82% | ||
| 1 month | -1.36% | ||
| 3 months | +4.32% | ||
| 6 months | +0.69% | ||
| Current year | -35.56% |
| 1 week | 8.4 |  | 9.04 |
| 1 month | 7.6 | | 9.07 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 28 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 302.9 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 23/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 01/07/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 25/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 26/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 25/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/3/22 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 24/3/22 | Others | Chairman | 120,000 | 0.0268% | ||
| 20/12/21 | Free | Chief Executive Officer | 2,250,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.36% | +3.82% | -65.06% | -66.41% | 10.16M | |
| -0.52% | +3.21% | +89.52% | +127.32% | 1,057B | |
| +0.88% | +1.13% | +49.56% | +49.69% | 625B | |
| +0.89% | -1.95% | +24.23% | +64.44% | 435B | |
| +0.71% | +3.87% | +49.07% | +37.85% | 363B | |
| +0.64% | -0.49% | +33.94% | +40.01% | 296B | |
| +0.39% | -5.83% | +8.92% | +7.85% | 249B | |
| +1.51% | +6.69% | +42.58% | +57.57% | 222B | |
| +3.92% | -0.46% | -5.56% | -52.32% | 209B | |
| +1.80% | +2.30% | +11.56% | +66.35% | 165B | |
| Average | +0.89% | +1.16% | +23.87% | +33.24% | 362.08B | |
| Weighted average by Cap. | +0.66% | +1.22% | +48.72% | +64.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -31M -3.27M -2.83M -2.64M -2.42M -4.56M -311M -4.63M -12.17M -156M -12.28M -12.01M -516M | -46M -4.85M -4.2M -3.92M -3.6M -6.76M -462M -6.87M -18.05M -232M -18.23M -17.83M -765M |
| Net Debt | -8M -844K -730K -682K -626K -1.18M -80.34M -1.2M -3.14M -40.27M -3.17M -3.1M -133M | -10M -1.06M -913K -852K -782K -1.47M -100M -1.49M -3.92M -50.33M -3.96M -3.88M -166M |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | SEK 8.700 | -1.36% | 13,151 |
| 06/08/26 | SEK 8.820 | -1.56% | 7,538 |
| 05/08/26 | SEK 8.960 | +0.45% | 9,640 |
| 04/08/26 | SEK 8.920 | +2.53% | 11,025 |
| 03/08/26 | SEK 8.700 | +3.82% | 11,631 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Select your edition
All financial news and data tailored to specific country editions
